Financials Scilex Holding Company

Equities

SCLX

US80880W1062

Pharmaceuticals

Real-time Estimate Cboe BZX 03:52:44 2024-05-17 pm EDT 5-day change 1st Jan Change
0.89 USD +2.30% Intraday chart for Scilex Holding Company +20.87% -55.83%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 564 199.6 105.4 - -
Enterprise Value (EV) 1 564 199.6 105.4 105.4 105.4
P/E ratio -23.5 x -1.59 x -2.56 x -3.73 x -4.35 x
Yield - - - - -
Capitalization / Revenue - 4.27 x 1.1 x 0.77 x 0.87 x
EV / Revenue - 4.27 x 1.1 x 0.77 x 0.87 x
EV / EBITDA - - - - -
EV / FCF - - -0.96 x -1.17 x -2.61 x
FCF Yield - - -104% -85.4% -38.2%
Price to Book - - - - -
Nbr of stocks (in thousands) 141,349 97,837 121,121 - -
Reference price 2 3.990 2.040 0.8700 0.8700 0.8700
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 46.74 95.68 137.6 121.3
EBITDA - - - - -
EBIT 1 - -105.4 -57.65 -52.42 -53
Operating Margin - -225.55% -60.25% -38.08% -43.69%
Earnings before Tax (EBT) 1 - -114.3 -59.93 -47.05 -53
Net income 1 -23.36 -114.3 -59.93 -47.05 -58.3
Net margin - -244.59% -62.64% -34.18% -48.06%
EPS 2 -0.1700 -1.280 -0.3400 -0.2333 -0.2000
Free Cash Flow 1 - - -109.7 -90 -40.3
FCF margin - - -114.65% -65.39% -33.22%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 10.12 13.46 10.88 23.18 25.34 29.4 35 38.65
EBITDA - - - - - - - - -
EBIT 1 - -38.8 -18.34 -19.48 -9.869 -11.15 -9.106 - -
Operating Margin - -383.56% -136.23% -178.96% -42.58% -44.01% -30.97% - -
Earnings before Tax (EBT) 1 - -35.53 -21.39 -24.38 -11.26 -12.1 -9.536 - -
Net income 1 -26.65 -35.53 -21.39 -24.38 -11.26 -12.1 -9.536 - -
Net margin - -351.18% -158.87% -223.97% -48.58% -47.76% -32.43% - -
EPS 2 -0.1900 -0.6300 -0.2500 -0.2400 -0.0850 -0.0900 -0.0700 -0.0700 -0.0450
Dividend per Share - - - - - - - - -
Announcement Date 8/11/23 11/14/23 3/12/24 5/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - - -110 -90 -40.3
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.87 USD
Average target price
5.5 USD
Spread / Average Target
+532.18%
Consensus
  1. Stock Market
  2. Equities
  3. SCLX Stock
  4. Financials Scilex Holding Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW